ECS Botanics Holdings Ltd (ASX:ECS)
Australia · Delayed Price · Currency is AUD 0.0080
0.00 (0.00%)
Aug 1, 2025, 10:00 AM AEST
Ligand Pharmaceuticals Market Cap
ECS Botanics Holdings has a market cap or net worth of 11.02 million as of August 1, 2025. Its market cap has decreased by -52.50% in one year.
Market Cap
11.02M
Enterprise Value
13.31M
Revenue
18.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 22, 2019, ECS Botanics Holdings's market cap has decreased from 32.99M to 11.02M, a decrease of -66.61%. That is a compound annual growth rate of -16.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 11.02M | -50.00% |
| Dec 31, 2024 | 22.03M | -11.52% |
| Dec 29, 2023 | 24.90M | 12.50% |
| Dec 30, 2022 | 22.13M | -35.40% |
| Dec 31, 2021 | 34.26M | 30.17% |
| Dec 31, 2020 | 26.32M | 5.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 131.27B |
| Pro Medicus | 33.40B |
| Cochlear | 20.72B |
| Sonic Healthcare | 13.69B |
| Ramsay Health Care | 8.94B |
| Telix Pharmaceuticals | 7.00B |
| Ansell | 4.38B |
| Mesoblast | 3.13B |